恰加斯心肌病中的心源性栓塞性卒中:心尖室壁瘤、左心室血栓与临床结局的相互作用
该前瞻性队列纳入518例确诊恰加斯心肌病患者,评估心尖室壁瘤与心源性栓塞性卒中的关联及后者对预后的影响。匹配分析显示心尖室壁瘤与心源性栓塞性卒中显著相关,其中63.3%通过左心室血栓形成介导;既往心源性栓塞性卒中与左心室血栓独立关联,但既往卒中或室壁瘤均与死亡或心脏移植复合结局无关。
要点
- 心尖室壁瘤增加栓塞风险主要通过左心室血栓介导,血栓是核心驱动因素。
- 既往心源性栓塞性卒中和左心室血栓独立预测新发心源性栓塞性卒中。
- 既往心源性栓塞性卒中或室壁瘤与死亡或心脏移植复合结局无关。
核心结论
- 在恰加斯心肌病中,心源性栓塞性卒中主要由左心室血栓形成驱动。
- 心尖室壁瘤主要通过血栓介导增加栓塞风险,既往心源性栓塞性卒中识别复发高风险患者。
研究设计与样本
- 前瞻性队列研究,2007至2022年在一家三级转诊中心纳入518例确诊恰加斯心肌病患者。
- 基线评估包括临床评估、心电图和超声心动图,缺血性卒中亚型采用病因分类系统分类。
主要发现
- 入组时73例(14.1%)有既往心源性栓塞性卒中史。
- 多变量分析中,NYHA III/IV级、较低左心室射血分数和左心室血栓与既往心源性栓塞性卒中独立相关,而心尖室壁瘤不相关。
- 匹配分析显示心尖室壁瘤与心源性栓塞性卒中显著相关,其中63.3%通过左心室血栓形成介导。
- 平均随访4.9年期间,174例死亡、22例接受心脏移植;NYHA III/IV级、右心衰竭、左心房扩大和较低左心室射血分数与死亡或心脏移植复合结局独立相关,既往心源性栓塞性卒中和心尖室壁瘤均与不良结局无关。
- 新发心源性栓塞性卒中41例(9%),与既往心源性栓塞性卒中和左心室血栓独立相关。
临床怎么用
- 在恰加斯心肌病患者中应重点关注左心室血栓检测以评估心源性栓塞性卒中风险。
- 对既往心源性栓塞性卒中患者应识别为复发高风险人群并考虑针对性预防策略。
- 心尖室壁瘤患者的栓塞风险监测应围绕血栓形成进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Apical aneurysm is a hallmark of Chagas cardiomyopathy (CCM) and has long been implicated in thromboembolic complications. However, its independent contribution to cardioembolic (CE) stroke and the mechanisms underlying this association remain incompletely understood. This study evaluated the association between apical aneurysm and CE stroke and assessed the prognostic implications of CE stroke in patients with CCM. METHODS: In this prospective cohort study, 518 patients with confirmed CCM were enrolled at a tertiary referral centre between 2007 and 2022. Baseline evaluation included clinical assessment, electrocardiography and echocardiography. Ischaemic stroke subtype was classified using the Causative Classification System. Logistic regression analyses examined factors associated with CE stroke. Genetic matching was used to assess the association between apical aneurysm and CE stroke while causal mediation analysis evaluated the contribution of left ventricular (LV) thrombus. Cox proportional hazards models assessed factors associated with all-cause mortality or heart transplantation. RESULTS: At enrolment, 73 patients (14.1%) had a history of CE stroke. In multivariable analyses, New York Heart Association (NYHA) functional class III/IV, lower LV ejection fraction and LV thrombus were independently associated with prior CE stroke, whereas apical aneurysm was not. However, matched analyses demonstrated a significant association between apical aneurysm and CE stroke, of which 63.3% was mediated through LV thrombus formation. During a mean follow-up of 4.9 years, 174 patients died and 22 underwent heart transplantation. NYHA functional class III/IV, right-sided heart failure, left atrial enlargement and lower LV ejection fraction were independently associated with the composite outcome of death or heart transplantation, whereas neither prior CE stroke nor apical aneurysm was associated with adverse outcomes. Incident CE stroke occurred in 41 patients (9%) and was independently associated with prior CE stroke and LV thrombus. CONCLUSION: In CCM, CE stroke is primarily driven by LV thrombus formation. Apical aneurysm increases embolic risk mainly through thrombus mediation, while prior CE stroke identifies patients at increased risk for recurrence. These findings support targeted stroke prevention strategies focused on thrombus detection and anticoagulation.
引用
- Teixeira Tupinambás J, Rocha MOC, Lage TAR, et al. Cardioembolic stroke in Chagas cardiomyopathy: the interplay between apical aneurysm, left ventricular thrombus and clinical outcomes. Heart. 2026. PMID: 42521491. doi:10.1136/heartjnl-2026-328159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。